Tags |
|
|
Links |
|
|
E-Articles - An Introduction To Nanotechnology
Nanotechnology is extremely inter-disciplinary, comprises of physics, chemistry, biology, materials science, and the full variet
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
y of the engineering disciplines. The word nanotechnology is been used widely as shorthand to refer to both the technology of em
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
erging field and science. Basically defined, nano-science comprises the basic understanding of physical, biological and chemical
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
properties on atomic and near-atomic scales. Nanotechnology, barely defined, employs controlled manipulation of these atomic pr
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
perties to make materials and as well other functional system with exclusive capabilities.
Contrary to recent engineering hard
Contrary to recent engineering hard
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
work, nature developed nanotechnologies over billions of years, employing enzymes and catalysts to manage with beautiful accurac
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
y various types of atoms and molecules into compound microscopic structures, which make life probable. These natural products ar
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
built with huge competence and have inspiring capabilities, like the power to yield solar energy, to change minerals and water
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
into livelihood cells, to store and procedure huge amounts of data using great arrays of nerve cells, and to copy completely bil
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
lions of bits of information stored in molecules of deoxyribonucleic acid (DNA).
Even more ground-breaking will be the manufact
Even more ground-breaking will be the manufact
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
re of nanoscale machines and nanoscale devices for integration into micro- and macro scale systems. Once again, nature has led t
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
he way with the manufacture of both linear and rotary molecular motors. These biological machines perform such tasks as muscle c
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ontraction (in organisms array from clams to humans) and carrying little packets of material around within cells as being powere
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
d by the eco-friendly, energy-efficient fuel adenosine triphosphate. Scientists are only starting to grow the tools to make func
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ioning systems at such small scales, with most proceeds based on electronic or magnetic date processing and other storage system
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
s. The energy-efficient, reconfigurable, and as well self-repairing aspects of biological systems are now becoming understood.
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
The likely impact of nanotechnology processes, machines, and products is predictable to be extensive, affecting almost every ima
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
inable information technology, energy source, farming product, medical device, pharmaceutical, and other material used in develo
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ped. In the meantime, the dimensions of electronic circuits on semiconductors carry on shrinking, with minimum characteristic si
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
zes now reaching the nanorealm, under 100 nanometers. They are huge markets driven by the fast advance of information technology
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/222488/e-article-An-Introduction-To-Nanotechnology.html">An Introduction To Nanotechnology</a>
BB link (for phorums):
[url=http://www.e-article.org.ua/article/222488/e-article-An-Introduction-To-Nanotechnology.html]An Introduction To Nanotechnology[/url]
Related Articles:
Why Life Insurance Should Be Part of Your Estate Planning
Ocean Wave Alternative Energies; Where Should They Be Located?
Bookmark it:
|